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Cell cycled of the Six1/2 subfamily are expressed throughout development of vertebrate
cranial placodes and are required for their differentiation into ganglia and sense organs. How they regulate
placodal neurogenesis, however, remains unclear. Through loss of function studies in Xenopus we show that
Eya1 and Six1 are required for neuronal differentiation in all neurogenic placodes. The effects of overexpression
of Eya1 or Six1 are dose dependent. At higher levels, Eya1 and Six1 expand the expression of SoxB1 genes (Sox2,
Sox3), maintain cells in a proliferative state and block expression of neuronal determination and differentiation
genes. At lower levels, Eya1 and Six1 promote neuronal differentiation, acting downstream of and/or parallel to
Ngnr1. Our ﬁndings suggest that Eya1 and Six1 are required for both the regulation of placodal neuronal
progenitor proliferation, through their effects on SoxB1 expression, and subsequent neuronal differentiation.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe cranial placodes, which contribute to the cranial ganglia and
sense organs of the vertebrate head, originate from the pre-placodal
ectoderm that surrounds the anterior neural plate (reviewed in Baker
and Bronner-Fraser, 2001; Bailey and Streit, 2006; Schlosser, 2006).
Genes of the Eya family and the Six1/2 and Six4/5 subfamilies are spe-
ciﬁcally expressed in this pre-placodal ectoderm and continue to be
expressed later in various placodes (Pandur and Moody, 2000; Ghan-
bari et al., 2001; David et al., 2001). Six proteins bind directly to DNA to
regulate gene transcription; interactions with various cofactors in-
cluding Eya modulate their activity (Pignoni et al., 1997; Ohto et al.,ersity of Bremen, FB 2 P.O. Box
49.
er).
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l rights reserved.1999; Ikeda et al., 2002). Mutants or morphants of Six1 and Eya1 in
mice, humans and zebraﬁsh display similar developmental deﬁcits
affecting multiple placodal derivatives (Xu et al., 1999, Zheng et al.,
2003; Li et al., 2003; Laclef et al., 2003; Zou et al., 2004; Ozaki et al.,
2004; Friedman et al., 2005; Kozlowski et al., 2005; Bricaud and
Collazo, 2006; Ikeda et al., 2007). In Xenopus, Six1 is required for the
formation of the pre-placodal ectoderm (Brugmann et al., 2004).While
thesemutant phenotypes suggest that Six1 and Eya1 play a central role
in the regulation of placodal neurogenesis the underlyingmechanisms
remain poorly understood.
Regulation of neurogenesis is particularly well studied in the Xe-
nopus neural plate (reviewed in Bertrand et al., 2002). Neuronal differ-
entiation is initiated by neuronal determination (proneural) genes
coding for basic helix loop helix (bHLH) transcription factors, such as
the neurogenin related gene Ngnr1 (Ma et al., 1996). These are tran-
siently expressed in proliferating neural progenitors, and promote cell
cycle exit and the expression of bHLH neuronal differentiation genes
such as NeuroD (Ma et al., 1996; Farah et al., 2000). Proneural proteins
also induce expression of ligands of the Notch pathway such as Delta1,
which prevent neighboring cells from adopting a neuronal fate (lateral
inhibition; Chitnis et al.,1995;Ma et al.,1996). Cell cycle exit is required
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inhibitors of cyclin dependent kinases including p27Xic1 (Hardcastle
and Papalopulu, 2000; Carruthers et al 2003). p27Xic1 also promotes
neuronal differentiation more directly, possibly by stabilizing Ngnr1
protein (Vernon et al., 2003; Nguyen et al., 2006). Neuronal
differentiation genes then activate batteries of neuron-speciﬁc genes
including N-Tubulin (Lee et al., 1995). However, neuronal differentia-
tion occurs only in a small subpopulation of neural plate cells; most
cells are kept in a proliferative progenitor state where differentiation
is blocked by various transcription factors including Sox1, Sox2 and
Sox3, members of the SoxB1 subfamily of HMG box containing
transcription factors (Bylund et al., 2003; Graham et al., 2003). In
addition, SoxB1 genes bias lineage choices of progenitor cells towards
a neural or neuronal fate (Mizuseki et al., 1998; Pevny et al., 1998;
Kishi et al., 2000; Zhao et al., 2004; Kan et al., 2004, 2007; Wang et al.,
2006).
Neurogenic placodes express many of the same genes that regulate
neurogenesis in the neural plate (Schlosser and Northcutt, 2000; Abu-
Elmagd et al., 2001; Vernon et al., 2003; Schlosser and Ahrens, 2004).
Ngn1, Ngn2 and NeuroD act as neuronal determination and differentia-
tion genes, respectively, in some placodes (Ma et al., 1998; Fode et al.,
1998; Liu et al., 2000; Kim et al., 2001). The phenotypes of mutants or
morphants of Eya1 and Six1 suggest that these genes are required both
for the proliferation and survival of placodal neuronal progenitors
(Zheng et al., 2003; Li et al., 2003; Bricaud and Collazo, 2006) as well as
for the proper expression of neuronal determination and differentiation
genes (Zou et al., 2004; Friedman et al., 2005; Bricaud and Collazo,Fig. 1. Placodal distribution of Sox3-immunopositive cells in relation to Six1, NeuroD, Delta1
shown in bright ﬁeld (A1–I1: gene expression), red ﬂuorescence (A2–I2: Sox3 protein), and a s
placodally derived cranial ganglia (main body of ganglia out of level of section in panels B, C
otic vesicle (A), anterodorsal lateral line (B) and facial epibranchial (C) placodes encompass S
otic vesicle (D), anterodorsal lateral line (E) and facial epibranchial placodes (F) immediately
(G), and the anterodorsal lateral line and glossopharyngeal epibranchial placodes and gangli
placode (I) overlap with some (black arrows) but not all (white arrows) Sox3-cells. Bar in I:2006; Ikeda et al., 2007). However, it is unclear which target genes
mediate the various effects of Eya1 and Six1. Herewe use gain- and loss-
of-function approaches in Xenopus to address this question. We show
that high levels of expression of Eya1 and/or Six1 promote proliferating
neuronal progenitors via activation of SoxB1 genes, while at lower
levels they permit cell cycle exit and promote neuronal differentiation
downstream of and/or parallel to Ngnr1. Our ﬁndings indicate that Eya1
and Six1 are required during multiple steps of placodal neurogenesis.
Materials and methods
Expression constructs
Six1, Eya1, Sox3 and GR–Sox3 mRNAs were made from pCS2+-Eya1α (Ahrens and
Schlosser, 2005), pDH105-Six1 (Pandur and Moody, 2000), pCS2-Sox3-V5His (Zhang et
al., 2003) and pCS2-GR-Sox3-GFP (Zhang and Klymkowsky, 2007) plasmids. Myc-tagged
Eya1 mRNA (myc-Eya) was made from pCS2+-myc-Eya1α generated by releasing the
insert from pT-Adv-Eya1α (David et al., 2001) with EcoRI and subcloning it downstream
of the myc-tag of pCS2+-myc. The construct was veriﬁed in immunoblot analyses fol-
lowing in vitro transcription and translation (TNT-coupled reticulocyte lysate kit,
Promega) using amouse anti-c-myc antibody (9E10, Developmental Studies Hybridoma
Bank). Myc-tagged or untagged versions of Eya1 mRNA had identical effects on all
markers analyzed.
To generate a hormone-inducible Eya1 expression vector (pCS2+-GR-myc-Eya1α),
the ligand-binding domain of the human glucocorticoid receptor (GR) plus the myc-tag
were released by digesting pCS2+-GR-myc (Hutcheson and Vetter, 2001) with BamHI
andNcoI. This fragmentwas inserted into the BamHI/NcoI site upstreamof Xenopus Eya1
replacing the myc-tag in the pCS2+-myc-Eya1α plasmid. To generate a hormone-
inducible Six1 expression vector (pCS2+-GR-myc-Six1), the full open-reading frame of
Xenopus Six1was generated by PCRwith primers containing XhoI sites and the pDH105-
Six1 plasmid (Brugmann et al., 2004). The Six1 fragment was inserted into the XhoI siteand Ngnr1 expression in transverse sections through stage 26 embryos. Each section is
uperposition of these two with blue DAPI ﬂuorescence (A3–I3). White asterisks indicate
and G). Black asterisks mark endodermal Sox3 nuclei. (A–C) Six1 expression domains in
ox3 immunopositive nuclei (arrows). (D–F) NeuroD is expressed in ganglia derived from
abutting Sox3-positive placodal cells (arrows). (G–I) Delta1 expression in the otic vesicle
a (H upper and lower part, respectively) and Ngnr1 expression in the facial epibranchial
50 μm (for all panels).
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and used as templates to generate mRNAs (GR–Six1 and GR–Eya1).
To ensure that GR-fusion constructs function comparable to wild-type protein,
injected embryos were cultured in dexamethasone (DEX) (10 μM) immediately after
mRNA injection. For each construct these embryos displayed nearly the identical
phenotype as those injected with the wild-type mRNAs (cf. Supplemental Table S1 to
Table 2 and Brugmann et al., 2004). Embryos injected with GR-constructs and raised in
the absence of DEX showed minimal effects (Supplemental Table S1) in accord with
published accounts of this method (Hollenberg et al., 1993; Mattioni et al., 1994, Kolm
and Sive, 1995; de Graaf et al., 1998). DEX treatment alone does not signiﬁcantly alter
gene expression (Supplemental Table S1).
Morpholinos
Morpholino antisense oligonucleotides (MO) against two different potential
translational start sites in Six1 (Six1MO1: 5′-GGAAGGCAGCATAGACATGGCTCAG-3′;Fig. 2. Effects of Eya1 and Six1 knockdown on markers of neurogenesis and placodal ectoder
protein. (B) Co-injecting Eya1MO2 or Eya1MO1+2 with myc-tagged Eya1mRNA signiﬁcantly re
three independent rescue experiments. (C–Q) Neural plate stage embryos after unilateral injecti
co-injected as lineage tracer (C–K), embryos are shown superimposed with green ﬂuorescent
gene expression. For Delta1 after Eya1MO1+2 injections two different phenotypes are depicted
control side) of Eya1MO1+2 reveals reduction ofNeuroD expression in all neurogenic placodes o
areas shownmagniﬁed in R5 and R6, respectively, superimposedwith green (myc-GFP co-injecte
to cells receiving little or no MO. Bar in R4: 100 μm (for R3, R4). Abbreviations: e: eye; epV
epibranchial placode; gVII/AV/AD: ganglion of the facial, anteroventral and anterodorsal lateral l
placode; pM: middle lateral line placode; pOl: olfactory placode; pP: posterior lateral line placSix1MO2: 5′-CGCACACGCAAACACATACACGGG-3′; both lissamine-tagged) were pre-
viously described and analyzed for speciﬁcity (Brugmann et al., 2004). Two different
MOs against Eya1 were generated (GeneTools): Eya1MO1 (5′-TACTATGTGGACTGGTTA-
GATCCTG-3′) targeted base pairs 10 to 34 of the Eya1 coding region, whereas Eya1MO2
(5′-ATATTTGTTCTGTCAGTGGCAAGTC-3′) was directed against base pairs −7 to −31 in
the 5′ UTR of Eya1 (EST BJ066588, Genbank). The efﬁcacy of Eya1MO1 was veriﬁed in
western blots following in vitro transcription and translation (TNT-coupled reticulocyte
lysate kit, Promega) of pCS2+-Eya1α (1 μg/25 μl reaction) with and without MO (1 μg of
MO/25 μl reaction) using guinea pig anti-Xenopus-Eya1 antibody as previously des-
cribed (Ahrens and Schlosser, 2005). MOs directed against the Sox2 (5′-CTCCAT-
CATGCTGTACATGCAGGCG-3′) and Sox3 (5′-AACATGCTATACATTTGGAGCTTCA-3′) UTR/
coding regions (Supplemental Fig. S1) were synthesized (GeneTools). To evaluate MO
efﬁcacy and speciﬁcity, epitope-tagged 5′ UTR-Sox2 and Sox3 constructs (pCS2-utr-
Sox3-V5 and pCS2-utr-Sox2-V5) that include the sequences targeted by the Sox2MO
and Sox3MO, respectively, were generated by PCR. A plasmid encoding ΔNXTCF3
(Molenaar et al., 1996) was supplied by Oliver Destree. mRNAs synthesized from pCS2-m. (A) Immunoblot showing that Eya1MO1 but not control MO blocks synthesis of Eya1
stores NeuroD and prevents ectopic p27Xic1 expression (Χ2 test; *: pb0.05, **: pb0.001) in
on (lower half) of Eya1MO1+2 (C–L) or Six1MO1+2 (M–Q). In all cases, wheremyc-GFPwas
channel. Asterisks indicate reductions, arrows and arrowheads indicate increased marker
(J, K). R: Tail bud stage embryo after unilateral injection (R1, R3, R5: injected side; R2, R4, R6:
r derivative ganglia. R3 and R4 depict a section at the level indicated (white line) with boxed
dwith Eya1MO1+2) and blue (DAPI) ﬂuorescence. ResidualNeuroD expression is conﬁned
II+AV: facial epibranchial and anteroventral lateral line placode; epIX: glossopharyngeal
ine nerve; gVIII: vestibulocochlear ganglion; nt: neural tube; pAD: anterodorsal lateral line
ode; pPr: profundal placode; pV: trigeminal placode; vOt: otic vesicle.
Table 1
Changes in marker gene expression in the placodal and non-neural ectoderm after
injection of Eya1 morpholinos
Injection Eya1 MO1a Eya1 MO2a
Phenotype %
(n)
%
(n)
Eya1
Reduced 40⁎⁎ 75⁎⁎
(15) (8)
Six1
Reduced 41⁎ 52⁎⁎
(17) (31)
Sox3
Reduced 8 29⁎
(26) (45)
Increased/ectopic 15⁎ 11⁎
(26) (45)
N-Tubulin
Reduced 58⁎⁎ 73⁎⁎
(40) (41)
Increased/ectopic 0 3
(40) (41)
NeuroD
Reduced 71⁎⁎ 68⁎⁎
(38) (79)
Ngnr1
Reduced 18 36⁎
(40) (50)
Increased/ectopic 38⁎⁎ 20⁎
(40) (50)
Delta1
Reduced 42⁎ 50⁎⁎
(19) (32)
Increased/ectopic 16⁎ 3
(19) (32)
n: number of embryos analyzed at neural plate (stage 14–16) and tail bud (stage 21–26)
stages.
a Signiﬁcant differences (Χ2 test; ⁎: pb0.05, ⁎⁎: pb0.001) to control MO injections
(see Table 2) are indicated.
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with Sox2 or Sox3 MOs (20 ng) and proteins were analyzed in western blots using anti-
V5 and anti-XTCF3c antibodies as previously described (Zhang et al., 2003). A standard
control MO (5′-CCTCTTACCTCAGTTACAATTTATA-3′) obtained from GeneTools was used
in control injections.
Microinjections
Embryos of Xenopus laevis were staged according to Nieuwkoop and Faber (1967)
and injected according to standard procedures (Sive et al., 2000). Capped mRNAs were
synthesizedwithMessageMachine Kit (Ambion) and injected into single blastomeres at
the 2- to 16-cell stage that give rise to the dorsal ectoderm. Unless otherwise noted, the
following amounts of mRNAs were injected: Eya1 or myc-Eya1: 500–1000 pg; Six1:
250–500 pg; GR–Eya1: 400–500 pg; GR–Six1: 400–500 pg; Sox3: 500 pg; GR–Sox3:
500 pg. Morpholinos (see above) were injected singly or as a cocktail (20 ng each) into
single blastomeres at the 2–16 cell stage. For rescue experiments, Eya1MO2 alone or in
combinationwith Eya1MO1 (20 ng each) were co-injectedwithmyc-Eya1 (250–500 pg).
GR–Eya1+GR–Six1 (500 pg each) were co-injected with a combination of Sox2MO and
Sox3MO (12–24ngeach). In injections of non-taggedmRNAormorpholinos, co-injection
of myc-GFP (125–250 pg) (pCMTEGFP; kindly provided by Doris Wedlich) or lacZ
(250 pg) identiﬁed the injected side. For activation of hormone-inducible constructs,
embryos were incubated in DEX (10 μM; Sigma) from stages 16–18 onwards. To block
protein synthesis, cycloheximide-treatment (50 μg/ml; Sigma) at stage 16–18 was
followed after 30′ by incubation in cycloheximide supplemented with DEX (10 μM) for
3–4 h at room temperature.
Tissue grafts
Grafts were performed as previously described (Ahrens and Schlosser, 2005). The
lateral placodal region of neural plate stage albino embryos injected unilaterally with
Eya1 (1000 pg) and myc-GFP (250 pg) at the 2-cell stage, was grafted orthotopically
into pigmented host embryos of the same stage. Uninjected donor embryoswere used in
control experiments.
In situ hybridization and immunohistochemistry
Embryos injected with myc-GFP or with tagged morpholinos were sorted under a
ﬂuorescent stereomicroscope and then ﬁxed according to standard procedures (Sive et
al., 2000). LacZ injected embryos were ﬁxed and then stained to reveal lacZ.
Wholemount in situ hybridization was carried out as previously described (Schlosser
and Ahrens, 2004) using digoxigenin-labeled antisense probes for Eya1 (David et al.,
2001), Six1 (Pandur andMoody, 2000), Sox3 (Penzel et al., 1997), Sox2 (De Robertis et al.,
1997),N-Tubulin (Oschwald et al., 1991),NeuroD (Lee et al., 1995),Ngnr1 (Ma et al., 1996),
Delta1 (Chitnis et al., 1995), p27Xic1 (Ohnuma et al., 1999), and CyclinA1 (Carter et al.,
2006).
After in situ hybridization, myc-tagged proteins were revealed immunohistochemi-
cally using mouse anti-c-myc antibody (9E10, Developmental Studies Hybridoma Bank)
as previously described (Ahrens and Schlosser, 2005). Phosphohistone H3 (PH3) was
identiﬁed with a rabbit anti-PH3 antibody (06-570, Upstate; 1:100) and revealed with
either anti-rabbit-TRITC (T-6778, Sigma, 1:100) or anti-rabbit-IgG-HRP (111-035-003,
Jackson ImmunoResearch,1:200) followed by reaction in diaminobenzidine (Dent et al.,
1989). PH3-immunopositive cells were counted in areas of deﬁned size in the lateral
placodal ectoderm of injected embryos. Uninjected sides of these embryos or lacZ
injected embryos served as control.
Vibratome sections (30 μm) were cut after whole mount in situ hybridization.
Immunohistochemistry on sections for myc-tagged proteins or Sox3 was performed as
previously described (Schlosser and Ahrens, 2004). Sox3was revealed using a polyclonal
rabbit anti-Sox3 antibody (Zhang et al., 2003; 1:1000) and a TRITC-conjugated anti-
rabbit-IgG antibody (T-6778, Sigma, 1:100). PCNA immunohistochemistry followed
published protocols (Wullimann et al., 2005) except that anti-mouse-IgG2a-TXRD
(1080-07, Southern Biotechnol., 1: 100) was used as secondary antibody. Secondary
antibodies were sometimes coincubated with DAPI (100 ng/μl). Nonspeciﬁc binding of
secondary antibodies was not observed when the primary antibody was omitted in
control reactions.
Results
Placodal neurons differentiate adjacent to Eya1 and Six1 expression
domains
As the pre-placodal ectoderm begins to separate into discrete
placodes, it maintains expression of Six1 and Eya1. Their expression
weakens in delaminating ganglion cells, which express several genes
regulating neurogenesis. (Pandur and Moody, 2000; Schlosser and
Northcutt, 2000; David et al., 2001). To determine the progression of
gene expression in placodal cells, we combined Sox3-immunostaining
with in situ hybridization for Eya1, Six1, NeuroD, Ngnr1 or Delta1 (Fig.1). Sox3-immunopositive nuclei were present in all neurogenic
placodes except the profundal and trigeminal placodes and were
always located fully within the expression domains of Six1 (Figs.1A–C)
and Eya1 (not shown). However, Sox3+ cells always constituted a
subpopulation in these domains. Expression of neurogenesis markers
was analyzed in otic, lateral line and epibranchial placodes. Each of
these expresses NeuroD and Delta1, whereas Ngnr1 is conﬁned to
epibranchial placodes. Delta1 and Ngnr1 were expressed in both the
placodes and in incipient ganglion cells migrating away from the
placodes. Delta1 and Ngnr1 expressing cells were both adjacent to
Sox3+ cells and overlappingwith them (Figs.1G, H), suggesting that: 1)
Sox3 expression is upstream of Delta1 and Ngnr1; and 2) cells that are
down-regulating Sox3 expression initiate the expression of neuronal
determination genes. In contrast, NeuroD expression was observed in
incipient ganglion cells immediately adjacent to, but not overlapping
with, Sox3+ nuclei (Figs. 1D–F). These results indicate that Sox3+
neuronal progenitors arise from the Eya1 and Six1-positive pool, then
initiate neuronal determination programs via Ngnr1 and Delta1, but
complete neuronal differentiation only after Eya1, Six1 and Sox3
expression declines.
Eya1 and Six1 are required for placodal neurogenesis
To test whether Eya1 and/or Six1 are required for placodal neuro-
genesis (Fig. 2, Tables 1, 2) we generated morpholino antisense oligo-
nucleotides (MOs) that speciﬁcally block translation of Six1 or Eya1
mRNAs. The efﬁcacy and speciﬁcity of the two Six1 MOs were pre-
viously reported (Brugmann et al., 2004). The efﬁcacy of Eya1MO1was
veriﬁed in vitro,where it strongly inhibited Eya1 protein synthesis (Fig.
2A). Both Eya1MO1 and Eya1MO2,when injected individually, affected
Table 2
Changes in marker gene expression in the placodal and non-neural ectoderm after injection of various constructs
Injection Control
MO
Eya1
MO1+2a
Six1
MO1+2a
Sox2MO+
Sox3MOa
Eya1 Six1 Eya1+Six1 Sox3 GR–
Eya1b
GR–
Six1b
GREya1+
GR-Six1b
GR–
Sox3b
Phenotype %
(n)
%
(n)
%
(n)
%
(n)
%
(n, np)
%
(n, tb)
%
(n, np)
%
(n, tp)
%
(n, np)
%
(n, tb)
%
(n)
%
(n, tb)
%
(n, np)
%
(n, tb)
%
(n, tb)
Eya1
Reduced 4 54⁎⁎ nd nd nd nd nd nd nd nd nd nd nd nd nd
(45) (39)
Increased/ectopic 0 15⁎ nd nd nd nd nd nd nd nd nd nd nd nd nd
(45) (39)
Six1
Reduced 8 45⁎⁎ nd nd 0 0 nd nd nd nd nd nd nd nd nd
(38) (81) (62) (77)
Increased/ectopic 0 0 nd nd 55 44 nd nd nd nd nd nd nd nd nd
(38) (81) (62)c (77)c
Sox3
Reduced 12 30⁎ 62⁎⁎ nd 29 53 52 59 85 90 nd 32 70 56 nd
(60) (156) (153) (52) (117) (46) (69) (40) (48) (34) (125) (135)
Increased/ectopic 0 12⁎ 0 nd 29 22 4 0 35 38 nd 32 39 63 nd
(60) (156) (153) (52) (117) (46) (69) (40) (48) (34) (137) (135)
Sox2
Reduced 6 58⁎⁎ 54⁎⁎ nd 30 50 86 71 42 36 68 35 58 46 nd
(32) (51) (26) (63) (38) (28) (68) (26) (25) (34) (40) (106) (52)
Increased/ectopic 0 26⁎ 0 nd 38 37 0 6 46 59 9 68 28 69 nd
(32) (31) (26) (63) (38) (28) (33) (26) (32) (34) (40) (114) (52)
N-Tubulin
Reduced 9 90⁎⁎ 66⁎⁎ 80⁎⁎ 60 48 88 86 79 88 91 41 41 43 42
(32) (206) (85) (40) (52) (42) (57) (14) (19) (17) (46) (41) (32) (82) (26)
Increased/ectopic 0 0 0 0 4 33 0 0 11 25 0 30 22 42 0
(32) (206) (85) (40) (52) (42) (57) (14) (19) (20) (46) (41) (32) (82) (26)
NeuroD
Reduced 24 79⁎⁎ 70⁎⁎ 75⁎⁎ 64 17 83 74 72 87 81 12 62 16 49
(89) (238) (182) (60) (63) (201) (78) (87) (39) (37) (67) (42) (141) (195) (78)
Increased/ectopic 0 1 0 0 3 45 0 0 5 87 0 52 29 71 0
(89) (146) (182) (60) (63) (201) (78) (87) (39) (37) (67) (42) (141) (195) (53)
Ngnr1
Reduced 10 21 45⁎⁎ 38⁎ 44 50 75 57 76 86 45 27 57 61 67
(41) (116) (75) (37) (50) (117) (68) (62) (45) (21) (51) (33) (136) (79) (30)
Increased/ectopic 0 34⁎⁎ 36⁎⁎ 38⁎⁎ 14 9 4 14 4 0 18 24 5 18 0
(41) (116) (75) (37) (50) (117) (68) (52) (45) (21) (51) (33) (168) (79) (30)
Delta1
Reduced 7 33⁎ 58⁎⁎ 69⁎⁎ 49 48 68 68 93 80 52 44 72 54 64
(30) (75) (79) (36) (33) (58) (40) (66) (27) (25) (60) (27) (127) (41) (36)
Increased/ectopic 0 22⁎ 18⁎ 0 27 4 48 0 0 0 32 0 2 10 0
(30) (75) (79) (36) (33) (58) (44) (66) (27) (25) (60) (27) (136) (41) (36)
p27Xic1
Reduced 17 22 29 42⁎ 43 76 75 82 80 nd 78 35 84 39 24
(35) (72) (59) (33) (115) (72) (60) (71) (10) (55) (161) (83) (209) (46)
Increased/ectopic 0 51⁎⁎ 34⁎⁎ 49⁎⁎ 48 20 15 0 0 nd 38 29 8 50 17
(35) (72) (59) (33) (115) (110) (40) (71) (10) (55) (161) (49) (209) (46)
CyclinA1
Reduced nd nd nd nd nd 2 0 0 nd nd nd 0 0 0 nd
(46) (27) (38) (112) (37) (91)
Increased/ectopic nd nd nd nd nd 0 0 0 nd nd nd 0 0 1 nd
(46) (27) (38) (112) (37) (91)
n: number of embryos analyzed at both neural plate (stage 14–16) and tail bud (stage 21–26) stage.
n, np: number of embryos analyzed at neural plate (stage 14–16) stage.
n, tb: number of embryos analyzed at tail bud (stage 21–26) stage.
nd: not determined.
a Signiﬁcant differences (Χ2 test; ⁎: pb0.05, ⁎⁎: pb0.001) to control MO injections are indicated.
b Dexamethasone treatment from stages 16–18 on.
c Expression broader but weaker.
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injection of both MOs produced a higher frequency of stronger
phenotypes (Tables 1, 2). Co-injection of a myc-tagged Eya1 mRNA
rescued the effects of Eya1MO2 or Eya1MO1+2 injection on NeuroD
and p27Xic1 expression (Fig. 2B), demonstrating that these MOs
speciﬁcally block Eya1 synthesis. Unless otherwise noted, control
MOs had no or signiﬁcantly less frequent effects on the markers
analyzed than injections of Eya1MO1+2 or Six1MO1+2 (Table 2).
Similar to ﬁndings after Six1 loss of function (Brugmann et al., 2004),
injection of Eya1MOs reduced expression of Eya1 and Six1 (Figs. 2C, D;
Table 2), demonstrating its requirement for establishing the pre-placodal ectoderm. In addition, injection of either Eya1MOs or Six1-
MOs resulted in signiﬁcant reduction of placodal neurons as evidenced
by reduced N-Tubulin and NeuroD expression in all neurogenic placodes
(Figs. 2G, H, N, O, R), corroborating results in mutantmice that Eya1 and
Six1 are required for neuronal differentiation in placodes (Zou et al.,
2004, Ikeda et al., 2007). We further demonstrate that this requirement
is cell-autonomous, since NeuroD is reduced in cells containing Eya1-
MOs (Fig. 2R). We then investigated which neurogenesis genes are
involved in the reduction of placodal neurons. Both Eya1MOs and
Six1MOs generally reduced placodal expression of Sox3 (Figs. 2F, M)
and Sox2 (Fig. 2E), although occasionally Eya1MOs led to an expansion
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as a broader, but more faintly stained expression domain or scattered
ectopic spots in the head. Loss of Eya1 or Six1 function often reduced
Ngnr1 (Fig. 2P) and Delta1 (Fig. 2K) expression domains, likely because
Eya1 and Six1 are required to establish the placodal ectoderm.
However, in about a third of the embryos Ngnr1 and Delta1 domains
were broadened (Figs. 2I, J), indicating that neuronal determination
proceeds more effectively when Eya1 or Six1 levels are reduced. Eya1
loss of function signiﬁcantly reduced the number of mitotic (PH3-
positive) cells (Fig. 9G), while reduction of either Eya1 or Six1 led to
the expansion of the p27Xic1 expression domain (Figs. 2L, Q), suggesting
a role in blocking the cell cycle exit that is necessary for neuronal
differentiation. These results demonstrate that loss of Eya1 and Six1
function interferes with proliferation, SoxB1 expression and neuronal
differentiation but allows neuronal determination to proceed. This
suggests a dual requirement for Eya1 and Six1 during placodal
neurogenesis upstream of SoxB1 genes as well as downstream of and/
or parallel to Ngnr1 and p27Xic1.
Eya1 and Six1 delay the onset of neuronal differentiation
To complement our loss of function studies,we overexpressedmyc-
tagged and untagged forms of Eya1 and Six1 either individually or in
combination by mRNA injection (Figs. 3–5, Table 2). Injection of Six1
and Eya1+Six1 mRNAs expanded the pre-placodal ectoderm at the
expense of neural crest and epidermal genes (Brugmann et al., 2004).
Likewise, injection of Eya1 mRNA led to broader and more diffuse
expression of Six1 in cranial ectoderm (Fig. 3A). However, injection of
Eya1, Six1 or Eya1+Six1mRNAs at levels that expand placodal ectoderm
tended to repress the expression of genes required for neurogenesis at
neural plate stages (Fig. 3, Table 2). Placodal Sox2 and Sox3 expression
were frequently reduced, in particular after Six1mRNA injection (Figs.
3B, C, K, O) while Eya1mRNA injection also caused ectopic expression
of low levels of Sox2 and/or Sox3 in both head and trunk ectoderm (Fig.
3D). Eya1 and/or Six1 overexpression reduced placodal expression of
Ngnr1, Delta1 and p27Xic1 (Figs. 3G, H, I, N). For Eya1-injected embryos,
Ngnr1 and Delta1 occasionally displayed a broader domain of expres-
sion, and ectopic p27Xic1 expression was observed in head and trunk
ectoderm in nearly half of the embryos (Fig. 3J). For Six1-injected
embryos, Ngnr1 and p27Xic1 were rarely expanded, whereas thisFig. 3. Effects of Eya1 and Six1 overexpression on markers of neurogenesis and placodal ecto
Six1 (K–N) or Eya1+Six1 (O)mRNA. In all cases, wheremyc-GFPwas co-injected as lineage trace
Black asterisks indicate reductions in the placodal or non-neural ectoderm. Arrows mark incr
arrowhead identiﬁes deformed blastopore due to gastrulation defects (O). For Sox3 (C, D) anphenotype occurred frequently for Delta1. Finally, both N-Tubulin
(Figs. 3E, L) and NeuroD (Figs. 3F, M) were strongly reduced by Eya1,
Six1 or Eya1+Six1.
To determine whether the effects of Six1 or Eya1 overexpression
were transient, similarly injected embryos were analyzed at tail bud
stages (Fig. 4, Table 2) when most placodes have separated and ini-
tiated neuronal differentiation. The effects of Eya1 and/or Six1 mRNA
injection on Sox3, Sox2, and Ngnr1 were similar to effects at neural
plate stages (Figs. 4A, B, F, I, K, M). The frequencies at which Delta1 and
p27Xic1 were expanded decreased signiﬁcantly (Figs. 4G, H, L). While
NeuroD andN-Tubulin continued to be frequently reduced, increased or
ectopic expression was now also observed after injection of Eya1
mRNA (Figs. 4C–E, J) in the vicinity of placodes and in spots throughout
head ectoderm. After co-injection of Eya1 and Six1 mRNAs, ectopic
spots of NeuroD expression in the cranial ectoderm occurred at high
frequency (Figs. 4N,10B). Often placodal expression of these geneswas
reduced throughout the region containing the exogenous Eya1 or Six1
mRNAs, with ectopic expression occurring at its border (Fig. 4D). These
data suggest that increased levels of Eya1 and Six1 delay the expression
of neuronal determination and differentiation genes, which ultimately
results in larger numbers of placodal neurons. Moreover, Eya1 and Six1
affect neuronal differentiation synergistically and Eya1 rather than
Six1 is limiting in vivo because ectopic neurons form only after Eya1
but not after Six1 overexpression.
To ensure that these phenotypes are not due to effects in the early
embryo, prior to the induction of the pre-placodal ectoderm, we
injected mRNAs encoding GR-fusion constructs of Eya1 and Six1 (GR–
Eya1, GR–Six1; see Supplemental Table S1 for validation). These
proteins were activated by adding DEX at neural fold stages (stage16–
18), when pre-placodal ectoderm has become committed (Ahrens and
Schlosser, 2005). Embryos were then analyzed at early tail bud stages.
The phenotypes observed were very much as described for wild-type
constructs analyzed at tail bud stages (Fig. 5; Table 2). However,
injection of GR–Eya1 or GR–Six1 led to higher frequencies of ectopic
expression of Sox3 (Fig. 5I) and Sox2 in head and trunk ectoderm; this
was particularly extensive after co-injection of both constructs.
Ectopic expression of Sox2 and Sox3 were seen only with GR–Six1
but not wild-type Six1. Similarly, ectopic expression of N-Tubulin and
NeuroD was only seen after GR–Six1 but not after wild-type Six1
injection.derm at neural plate stages. Embryos after unilateral injection (lower half) of Eya1 (A–J),
r (A–D, F–I, K, L, N, O), embryos are shown superimposedwith greenﬂuorescent channel.
eased or ectopic marker gene expression in the placodal or non-neural ectoderm; black
d p27Xic1 (I, J) after Eya1 injections two different phenotypes are depicted.
Fig. 4. Effects of Eya1, Six1 and Eya1+Six1 overexpression on various neurogenesis markers at tail bud stages (stage 26). Injected (A1–N1) and control (A2–N2) sides of tail bud stage
embryos after unilateral injection of Eya1 (A–H), Six1 (I–L) or Eya1+Six1 (M, N) mRNAs. In all cases, wheremyc-GFPwas co-injected as lineage tracer (A–G, M–N), embryos are shown
superimposed with green ﬂuorescent channel. Black asterisks indicate reductions, while black arrows mark increased or ectopic marker gene expression in the placodal or non-
neural ectoderm. Yellow asterisks identify expression in pharyngeal pouches. For Sox3 (A, B) and NeuroD (C, D) after Eya1 injections two different phenotypes are depicted.
Abbreviations as in Fig. 2. gPrV: profundal-trigeminal ganglionic complex; L: lens placode; PN: pronephros.
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the pool of proliferative SoxB1-positive neuronal progenitors
One explanation for the diverse phenotypes observed involves a
threshold effect; at protein levels above the threshold level these
proteins act tomaintain cells in a SoxB1-positive proliferative neuronal
progenitor state, whereas below this level ectopic neurons can
differentiate from the expanded pool of progenitors. This model was
supported by injecting increasing doses of GR–Eya1+GR–Six1 followed
by DEX activation at stage 16–18 (Fig. 6). The frequency of embryos
with ectopic Sox3 expression as well as the extent of ectopic Sox3
expression increased with increasing doses of injected Eya1 and Six1
mRNA (although Sox3 expression in the placodes was often reduced)
(Fig. 6A). In contrast, the frequency and extent of increased and/or
ectopic expression of Ngnr1 or NeuroD declined and the frequency andextent of reductions in p27Xic1, Ngnr1 or NeuroD expression increased
(Fig. 6B–D). This suggests that increasing concentrations of Eya1 and
Six1 increasingly delay cell cycle exit. In contrast to Ngnr1 and
NeuroD, frequency and extent of increased and/or ectopic expression
of p27Xic1 also increased with increasing doses of injected Eya1 and
Six1 mRNA (although p27Xic1 expression in the placodes was often
reduced in the same embryos) (Fig. 6B), suggesting that high levels of
Eya1 and Six1 prevent onset of neuronal differentiation even in cells
that have left the cell cycle.
In addition, analysis of the expression domains of neurogenesis
genes in relation to injected Eya1 or Six1 in tissue sections through
the placodal region of tail bud embryos showed that in ectoderm
containing exogenous Eya1, identiﬁed by myc-immunostaining,
N-Tubulin, NeuroD, Ngnr1, p27Xic1 and Delta1 were repressed, whereas
residual and ectopic expression were located in adjacent areas
Fig. 5. Effects of overexpression of GR–Eya1 or GR–Eya1+GR–Six1 on various neurogenesis markers at tail bud stages (stage 26). Injected (A1–N1) and control (A2–N2) sides of tail bud
stage embryos after unilateral injection of GR–Eya1 (A–H) or GR–Eya1+GR–Six1 (I–N) and DEX activation at stage 16–18. In all cases, wheremyc-GFPwas co-injected as lineage tracer
(A–F, I–M), embryos are shown superimposed with green ﬂuorescent channel. Black asterisks indicate reductions, while black or white arrowsmark increased or ectopicmarker gene
expression in the placodal or non-neural ectoderm. Yellow asterisks identify expression in pharyngeal pouches. For NeuroD (C, D) and p27Xic1 (G, H) after GR–Eya1 injection two
different phenotypes are depicted. Abbreviations as in Figs. 2 and 4.
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GR–Eya1 and co-expression with Six1 or GR–Six1.
To test whether this distribution of neuronal differentiation is due
to non-cell autonomous action of Eya1, we orthotopically grafted
placodal ectoderm from Eya1 mRNA injected embryos or uninjected
control embryos into uninjected hosts (Fig. 8). While some reduc-
tions of placodal NeuroD expression were observed in grafts from
both control (2/5) and Eya1 injected (10/19) embryos, an ectopic
increase of NeuroD expression was only observed in grafts from Eya1
injected donors (5/19) and was conﬁned to the graft. This indicates
that Eya1 promotes neuronal differentiation in a cell-autonomous
fashion.
High levels of Eya1 appear to be incompatible with high levels of
Sox3 expression since native Sox3 expression domains in the placodesare repressed in areas of intense exogenous Eya expression. At the
same time, there is ectopic low level expression of Sox3 throughout
these regions, and the ectoderm is dramatically thickened and contains
multiple layers of cells compared to the thin bilayered ectoderm on the
control side (Fig. 9A–C). Sox3-expressing cells within these ectodermal
thickenings are immunopositive for proliferating cell nuclear antigen
(PCNA), indicating that the thickenings result from increased prolif-
eration (Figs. 9A, B).
To quantify the effects on cell proliferation we counted nuclei
immunopositive for PH3, a marker for cells in mitosis (Saka and
Smith, 2001), in the placodal region after injection of mRNAs
encoding wild-type Eya1 and/or Six1. Each signiﬁcantly increased
the proportion of PH3-positive cells at neural plate stages and co-
injection augmented this effect (Figs. 9D–G). By neural tube stages the
Fig. 6. Dose-dependent effects of Eya1 on neurogenesis markers. Changes in placodal expression of Sox3 (A), p27Xic1 (B), NeuroD (C), and Ngnr1 (D) at stages 21–26 after injecting one
blastomere at the two cell stage with various doses of GR–Eya1+GR–Six1 mRNA followed by DEX activation at stage 16–18. For all markers analyzed, reductions of marker gene
expressionwas categorized as weak (less than 50% reduced) or strong (more than 50% reduced), while increased or ectopic marker gene expressionwas categorized as being conﬁned
to the vicinity of placodes (placodes), extending to other parts of head ectoderm (head) or extending into trunk ectoderm (trunk). Note that reductions in placodal marker gene
expression were sometimes associated with increased and/or ectopic marker gene expression elsewhere in the same embryo.
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transient response. After injections of mRNA encoding GR–Eya1 and/
or GR–Six1 and DEX activation at neural fold stages, a similar
signiﬁcant increase of the mitotic index was observed (Fig. 9G).
These results are compatible with the observation that both wild-type
and inducible forms of Eya1 and Six1 reduced placodal expression of
p27Xic1 (Figs. 3I, 4H, L, 5G, N), indicating that they delay cell cycle exit.
However, neither Eya1 nor Six1 affected CyclinA1 expression in the
developing placodal ectoderm (Table 2), indicating that neuronal
progenitor pool expansion is mediated by other target genes of Eya1
and Six1.
Taken together these ﬁndings substantiate the proposal that high
levels of Eya1 and Six1 synergistically delay cell cycle exit and prevent
neuronal differentiation but promote the proliferation of SoxB1-
positive neuronal progenitor cells. To conﬁrm that the ectopic neurons
observed in areas of low exogenous Eya1 and Six1 expression originate
from Sox3+ neuronal progenitors, we examined NeuroD expression in
relation to Sox3-immunostaining (Fig. 10). While Sox3-immunostain-
ing and NeuroD expression are mutually exclusive, ectopic NeuroD
expressing cells are found adjacent to Sox3+ cells and someof the latter
are localized within ectoderm expressing high levels of exogenous
Eya1 (Fig.10A) or Eya +Six1 (Fig.10B). This spatial relationship suggests
that Sox3+ cells differentiate as neurons once Eya1 and Six1 levels
decline below a certain threshold.Eya1 and Six1 control placodal neurogenesis in a SoxB1-dependent
fashion
Ourmodel implies that Eya1 and Six1modulate placodal neurogen-
esis in a SoxB1-dependent fashion. To test this hypothesis, we injected
either SoxB1 morpholinos or mRNAs into one blastomere at the two
cell stage and analyzed neurogenesismarker expression at neural plate
and tail bud stages (Fig. 11, Table 2). To test efﬁcacy and speciﬁcity of
MOs designed to block the translation of Sox2 and Sox3 mRNAs
(Supplemental Fig. S1), we co-injected them together with utr-Sox2
and utr-Sox3mRNA into fertilized eggs. The Sox2MO inhibited protein
synthesis from the utr-Sox2 mRNA but not from the utr-Sox3 mRNA
and vice versa (Fig. 11A). Neither MO affected TCF3 synthesis, an
internal control.
In embryos co-injected with Sox2 and Sox3morpholinos, N-Tubulin
(Fig. 11B) and NeuroD expression (Fig. 11C) were strongly repressed in
all neurogenic placodes including the profundal and trigeminal
placodes. Delta1 expression was also strongly repressed (not shown)
suggesting that reduced neuronal differentiation was not due to an
increase in lateral inhibition. On the other hand, the expression of
p27Xic1 and Ngnr1 was sometimes reduced but often enhanced in the
placodal region (Fig. 11D, E). Thus, Sox2 and Sox3 appear essential for
maintaining cells in the cell cycle and to promote neuronal differ-
entiation after cell cycle exit, since elevation of p27Xic1 and Ngnr1 after
Fig. 7. Dose-dependent effects of Eya1 on neurogenesis markers as revealed in tissue sections. Distribution of N-Tubulin (A), NeuroD (B), Ngnr1 (C) and Delta1 (D) in stage 26
embryos after injection of myc-Eya1 or co-injection of Eya1 with myc-GFPmRNA. Embryos are shown as wholemounts (injected side: A1–D1; control side: A2–D2) and in transverse
sections (at level indicated by black line) shown in bright ﬁeld (A3–D3), superimposition of green (myc-immunostaining) and blue (DAPI) ﬂuorescence (A4–D4, no DAPI image
available in panel D), and as a merged image (A5–D5). Boxed areas are magniﬁed in inserts. The DAPI channel is not shown in the inserts of panel C to make Ngnr1 staining more
clearly visible. Hatched boxed area in panels C3–C5 shows Ngnr1 positive epibranchial placode on control side in an adjacent section. Asterisks indicate reductions, while arrows
mark ectopic marker gene expression in the placodal or non-neural ectoderm. Double arrows identify areas of residual expression. Arrowheads mark displaced otic vesicle on
injected side. Bar in panel D5: 100 μm (for A3–5 – D3–5).
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differentiation.
Overexpression of Sox3, however, reveals that high levels of SoxB1
proteins are incompatible with neuronal differentiation. Injections of
Sox3 or of GR–Sox3 followed by DEX activation at stages 16–18 gave
similar results. N-Tubulin (Fig. 11F, J) and NeuroD (Fig. 11G, K) were
strongly repressed in all neurogenic placodes and the Sox3-over-
expressing regions of the ectoderm were thickened and PCNA-immunopositive (not shown). However, unlike the results with Eya1
or Six1, we never found ectopic expression of N-Tubulin or NeuroD.
p27Xic1 (Fig. 11I), Ngnr1 (Fig. 11H, L) and Delta1 (not shown) were
mostly reduced by increasing Sox3 or GR–Sox3 levels although
increased or ectopic expression was sometimes observed, indicating
that Sox3 overexpression delays cell cycle exit and onset of neuronal
differentiation. Increasing Sox3 expression, therefore, mimics many of
the effects of Eya1 and Six1 on placodal neurogenesis suggesting that
Fig. 8. Cell-autonomous effects of Eya1 on placodal neurogenesis. Panels show distri-
bution of NeuroD in grafts of placodal ectoderm from embryos injected with Eya1 and
myc-GFP mRNA to uninjected hosts. Boxed area is magniﬁed in insert of panel A. Insert
of panels A and C are shown superimposed with green ﬂuorescent channel to reveal
myc-immunostaining. While NeuroD expression in profundal (pPr) and trigeminal (pV)
placodes is reduced in the graft (asterisk, A, C) compared to control side (B), NeuroD is
expressed ectopically (arrow) at graft border but not in host ectoderm (A, C).
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injection, Sox3 injection never led to ectopic neuronal differentiation
indicating that Eya1 and Six1 probably promote neuronal differentia-
tion by additional and Sox3-independent mechanisms.
To directly test whether Eya1 and Six1 promote placodal neurogen-
esis in a SoxB1 dependent fashion, we injected GR–Eya1+GR–Six1 to-
gether with Sox2MO and Sox3MO followed by DEX activation at stage
16–18. Co-injection of SoxB1 MOs signiﬁcantly compromised the
ability of GR–Eya1+GR–Six1 to generate ectopic NeuroD expression
(Figs. 11M, N). To determine whether SoxB1 genes are direct target
genes of Eya1 and Six1we treated GR–Eya1+GR–Six1 injected embryos
with the protein synthesis inhibitor cycloheximide (CHX) prior to and
during DEX activation at stage 16–18. Eya1 and Six1 retained the ability
to ectopically induce Sox2 (Figs. 11P, R) and Sox3 (Figs. 11O, R) under
these conditions, indicating that the latter are likely direct targets of
transcriptional regulation by Eya1 and Six1. Ectopic induction of Sox2
and Sox3 was stronger and more frequent with CHX treatment sug-
gesting that there also is an indirect inhibitory effect on Sox2 and Sox3
expression that is relieved when protein synthesis is blocked. Ectopic
NeuroD and p27Xic1 expression were no longer observed after CHX
treatment (Figs. 11Q, R) indicating that these genes are likely to be
indirect targets of regulation by Eya1 and Six1.
Discussion
Eya1 and Six1 regulate several steps in placode development
Eya1 and Six1 are required for establishing the pre-placodal
ectoderm in Xenopus and distinguishing it from the adjacent neural
crest and non-neural epidermis (Brugmann et al., 2004). In addition,
members of the Eya and Six1/2 gene families have important roles in
the proliferation and survival of neuronal and sensory progenitors
(Zheng et al., 2003; Li et al., 2003; Bricaud and Collazo, 2006; Zou et al.,
2006; Kriebel et al., 2007) as well as for the proper expression of
neuronal determination and differentiation genes in the olfactory, otic
and epibranchial placodes (Zou et al., 2004; Friedman et al., 2005;
Bricaud and Collazo, 2006; Ikeda et al., 2007). We have extended these
observations to demonstrate that both Eya1 and Six1 are required for
neuronal differentiation in all neurogenic placodes, substantiating the
suggestion that Eya1 and Six1 have pan-placodal functions (Schlosser,
2006). In addition, we show that they are important in multiple steps
during placodal neurogenesis, that their speciﬁc roles are determined
by their levels of expression, andmany of their effects aremediated by
SoxB1 genes (Fig. 12).After establishing the pre-placodal ectoderm, Eya1 and Six1 con-
tinue to be expressed at high levels in the developing placodes (Pandur
and Moody, 2000; Schlosser and Northcutt, 2000; David et al., 2001).
We show that a subset of these cells express Sox2 and Sox3, and that
Eya1 and Six1 are required for Sox expression. Our expression analysis
suggests that incipient placodal neurons are mostly Eya1, Six1 and
Sox3-negative but originate from Sox3+ cells. This extends observa-
tions in the zebraﬁsh and chick, where neurons in the otic and
epibranchial placodes were found to differentiate from Sox3+ cells
(Abu-Elmagd et al., 2001; Neves et al., 2007; Sun et al., 2007;Nikaido et
al., 2007). It appears that it is the reduction of Eya1 and Six1 protein
levels that permits expression of neuronal determination and
differentiation markers. Thus, levels of expression of Eya1 and Six1
regulate the progression from proliferating placodal progenitor to
differentiated placodal neuron (Fig. 12).
High levels of Eya1 and/or Six1 maintain cells in a proliferative neuronal
progenitor state
Our gain-of-function experiments suggest that at high levels of
expression Eya1 and Six1 keep cells in a proliferative neuronal
progenitor state and block onset of neuronal determination. Although
Six1 is able to directly activate cell cycle regulators such as CyclinA1
and c-Myc (Li et al., 2003; Coletta et al., 2004), neither Eya1 nor Six1
affected CyclinA1 expression in our experiments. This suggests that
other target genes of Eya1 and Six1 are involved in progenitor pool
expansion. Our ﬁnding that Sox2 and Sox3 are likely direct targets of
Eya1 and Six1 suggests that SoxB1 genes may be involved in this
process.
SoxB1 genes are well known to be required for neuronal differ-
entiation in the central nervous system and to bias lineage choice
towards neural or neuronal fates (Pevny et al., 1998; Kishi et al., 2000;
Zhao et al., 2004; Kan et al., 2004, 2007; Wang et al., 2006). However,
overexpression of SoxB1 genes interferes with neuronal differentia-
tion and often reduces Ngnr1 and p27Xic1 expression (Bylund et al.,
2003; Graham et al., 2003; Hardcastle and Papalopulu, 2000), while
loss of SoxB1 function increases their expression, indicating that
SoxB1 proteins maintain a proliferative neural or neuronal progenitor
cell. Our loss of function experiments show that neuronal differentia-
tion in placodes is blocked even though p27Xic1 and Ngnr1 are
frequently increased indicating that SoxB1 genes are also required for
neuronal differentiation in placodes, acting either downstream of
and/or parallel to p27Xic1 and Ngnr1. However, we also observed that
increasing Sox3 expression in the placodal ectoderm reduced the
expression of both neuronal determination and differentiation genes,
while knockdown could expand Ngnr1 and p27Xic1. These ﬁndings
suggest that SoxB1 genes play a dual role in the neurogenic placodes
as they do in the CNS: they are (1) required for neuronal differen-
tiation, but (2) maintain cells in a proliferative neuronal progenitor
state.
Surprisingly, we ﬁnd SoxB1 genes to be required for neuronal
differentiation even in the profundal and trigeminal placodes, which
do not express Sox2 or Sox3 from neural plate stages on (Schlosser and
Ahrens, 2004). These are the earliest placodal neurons to be born and
to differentiate (Lamborghini, 1980; Schlosser and Northcutt, 2000),
and therefore may be inﬂuenced by the more widely expressed Sox2/
Sox3 at gastrula stages (Penzel et al., 1997; Mizuseki et al., 1998).
Our experiments demonstrate that Sox2/Sox3 are regulated in the
placodes by Eya1 and Six1. Loss- and gain-of-function of either Eya1 or
Six1 affect neuronal determination and differentiation genes in a
similar manner to the loss- and gain-of function of Sox2/Sox3, sug-
gesting that these two sets of transcription factors act in the same
pathway. Furthermore, the endogenous expression of Sox2 and Sox3 in
the placodes is conﬁned to domains of Eya1 and Six1 expression, and
requires both of these genes. These data suggest that the ability of Eya1
and Six1 to promote proliferative neuronal progenitors, from which
Fig. 9. Eya1 and Six1 promote proliferative SoxB1-positive neuronal progenitors. (A–C) Transverse sections through neural plate (A) or tail bud stage (B, C) embryos that received
unilateralmyc-Eya1mRNA injection at the two cell stage. (A, B) Panels show Sox3 expression in bright ﬁeld (A1–B1), distribution of injected myc-Eya1 protein (A2–B2), PCNA together
with DAPI staining (A3–B3) and a merged image (A4–B4). (C) Panels show distribution of injected myc-Eya1 protein (C1), PCNA (C2) and a merged image (C3) together with DAPI
staining. Ectoderm that received high levels of Eya1 expresses Sox3 (A1–B1, arrows), is drastically thickened (A1–C1, red lines) compared to control side (black or white lines) and
consists of multiple layers of PCNA positive cells (A3, B3, C2). The otic vesicle has failed to form on the injected side of embryos in panels B and C. Arrowheads identify cells
coexpressing myc-Eya1 and PCNA. Double arrows in panel C identify the basal lamina of the ectoderm on the injected side. Abbreviations: nt: neural tube. vOt: otic vesicle. All bars:
100 μm. (D–G) Effects of Eya1 and Six1 gain and loss of function on phosphohistone H3 (PH3). (D–F) PH3 immunopositive nuclei in placodal ectoderm of neural plate stage embryos
after injection of lacZ (D) Eya1+lacZ (E) or Eya1+Six1+ lacZ mRNAs (F). (G) Relative mitotic index after injections of Six1 or Eya1 mRNAs or morpholinos. Standard deviations and
signiﬁcant increases are indicated (t-test; *: pb0.05, **: pb0.001).
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activate SoxB1 expression (Fig. 12). We conﬁrmed this by showing that
SoxB1 knockdown interferes with the ability of Eya1 and Six1 to induce
ectopic neurons. Our gain-of-function experiments further suggest
that when expressed at high levels Eya1 and Six1 promote a proli-
ferative SoxB1+ neuronal progenitor state. As levels of expression of
both sets of genes begin to decrease, the SoxB1+ cells transition to a
state in which cell cycle exit is permitted, the neuronal fate is deter-mined, and neurons differentiate from an expanded pool of neuronal
progenitors.
Low levels of Eya1 and/or Six1 promote neuronal differentiation
Our observation that ectopic neuronal differentiation occurs only
after Eya1 or Six1 but not after Sox3 overexpression, indicates that low
levels of Eya1 and Six1 do not merely play a permissive role for the
Fig. 10. Ectopic neurons in embryos overexpressing Eya1 or Eya1+Six1 originate from
Sox3 immunopositive neuronal progenitors. Panels show distribution of NeuroD
expressing cells in relation to Sox3-immunopositive cells in tail bud stage embryos
after injection of myc-Eya1 mRNA alone (A) or together with Six1 mRNA (B). Embryos
are shown as wholemounts (injected side: A1–B1; control side: A2–B2) and in transverse
sections (at level indicated by black line). Panels show bright ﬁeld images (A3–B3), myc-
immunostaining together with DAPI (A4–B4), Sox3-immunostaining together with DAPI
(A5–B5), and merged images (A6–B6). Asterisks indicate reductions, while arrows mark
ectopic NeuroD expression in the non-neural ectoderm. Ectopic NeuroD expression is
found next to Sox3 immunopositive cells on the fringes of ectodermal regions that
received high levels of myc-Eya1. Sox3 cells reside in ectoderm that received high levels
of myc-Eya1 (arrowheads) as well as in areas of lower myc-Eya1 levels immediately
abutting NeuroD expressing cells (double arrows). Boxed areas are shown at higher
magniﬁcation in inserts. All bars: 100 μm
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differentiation downstream of and/or in parallel to Sox3 (Fig. 12).
Furthermore, we do not observe ectopic neuronal differentiation in
Eya1 or Six1 loss of function experiments even though Ngnr1 and
p27Xic1 are often increased. This suggests that Eya1 and Six1 are both
required for neuronal differentiation to proceed beyond expression of
proneural genes.
Neurogenesis in different placodes is known to rely on different
proneural genes with interspeciﬁc differences between vertebrates.
In mammals, neuronal determination depends on Ngn1 in the tri-
geminal and otic placodes, on Ngn2 in the epibranchial placodes
and on Ash1 in the olfactory placode (Fode et al., 1998, Ma et al., 1998;
Cau et al., 2002), while in the zebraﬁsh neuronal determination in all
(except possibly the olfactory placodes) depends on ngn1 (Andermann
et al., 2002). Although two different Ngn genes are also present in
Xenopus (Furlong and Graham, 2005), only the expression of the
Ngn2 homologue Ngnr1 has been described and it is conﬁned to the
olfactory, profundal/trigeminal and epibranchial placodes (Schlosser
and Northcutt, 2000). This suggests that in Xenopus similar to
amniotes, neuronal determination in different placodes relies on dif-
ferent neuronal determination genes and that possibly the Xenopus
Ngn1 homologue may play this role in placodes that do not express
Ngnr1 (otic and lateral line placodes). Because knockdown of Eya1or Six1 blocks neuronal differentiation in placodes that express Ngnr1
as well as in those that do not express it,we propose that these genes
promote neuronal differentiation both downstream of and/or in
parallel to Ngnr1 and via other pathways (possibly downstream of
and/or in parallel to other neuronal determination genes such as
Ngn1).
Increased levels of Eya1 or Six1 also reduce Delta1, suggesting that
relief of Notch-mediated lateral inhibition (Chitnis et al., 1995) allows
Eya1 and Six1 to promote ectopic neuronal differentiation. However,
several observations indicate that this is unlikely to be a major
contributor. First, repression of Delta1 is conﬁned to regions of high
levels of Eya1 and Six1, where cells maintain a proliferative progenitor
state, whereas ectopic neuronal differentiation occurs in adjacent
regions, which maintain Delta1 expression. Second, Ngnr1 as well as
NeuroD is expected to be increased after relief of lateral inhibition
(Ma et al., 1996), which we did not observe. Third, increases in Delta1
after Six1 or Eya1 loss-of-function are observed much too rarely to
account for the frequent reductions in neuronal differentiation.
Are other factors interacting with Eya1 and/or Six1 in placodal
neurogenesis?
In the experiments presented herein, Eya1 and Six1 have similar
effects on the expression of most neurogenesis markers and the
phenotypes were stronger after co-expression of both. These results
support their known ability to directly interact to affect transcription
(Ohto et al., 1999; Ikeda et al., 2002). However, other Eya genes and
genes of the Six1/2 and Six4/5 subfamilies are also expressed in
multiple placodes in different vertebrates with some interspeciﬁc
differences in expression patterns (Brugmann and Moody, 2005;
Schlosser, 2006). This suggests that some of these other genes may
also be involved in the regulation of placodal neurogenesis perhaps
with redundant functions. Indeed, in mice trigeminal neurogenesis is
affected only in Six1/Six4 double knockouts but not in mutants of
either gene alone (Konishi et al., 2006). In Xenopus, Six2 and Six4 are
expressed in most placodes similar to Six1 (Ghanbari et al., 2001).
Xenopus Eya3 is not strongly expressed in the pre-placodal ectoderm,
in contrast to Eya1, but subsequently is expressed in the lens and otic
placodes, while the expression of other Xenopus Eya genes has not yet
been reported (Kriebel et al., 2007). Taken together, this suggests that
Six2, Six4, Eya3 and possibly other uncharacterized family members
(Six5, Eya2, Eya4) as well may cooperate with Six1 and Eya1 in
regulating neurogenesis in at least some placodes in Xenopus.
From our experiments, we noted that Eya1 and Six1 effects were
not always identical. Eya1MOs caused expansion of Sox2 and Sox3
whereas Six1MOs did not. Injection of Eya1 mRNA expanded Ngnr1
and p27Xic1 domains more frequently and reduced SoxB1 expression
less frequently than did injection of Six1 mRNA. Finally, Eya1 knock-
down had amuch smaller effect on Sox3 compared to Six1 knockdown.
These results suggest that both Eya1 and Six1 may synergize with
some other factors during placodal neurogenesis.
In conclusion, we have identiﬁed multiple previously unrecog-
nized roles of Eya1 and Six1 in the regulation of placodal neurogenesis.
Based on the data presented herein, we propose a model of the gene
cascade regulating this important developmental process (Fig. 12).
High levels of Eya1 and Six1 expression in the neurogenic placodes
promote a SoxB1-dependent proliferative neuronal progenitor state
and block onset of neuronal determination. As Eya1 and Six1 are
downregulated, SoxB1 expression subsides and cell cycle inhibitors
(p27Xic1) and proneural genes (Ngnr1 or other unidentiﬁed genes) are
de-repressed, thereby permitting neuronal determination and differ-
entiation to proceed. Low Eya1, Six1 and SoxB1 expression levels then
promote neuronal differentiation downstream of and/or in parallel to
Ngnr1 and possibly other proneural genes. Because Eya1 and Six1 only
promote neuronal differentiation in cranial ectoderm, additional
regionalized and yet unidentiﬁed factors must contribute to the
Fig. 11. Role of SoxB1 genes in placodal neurogenesis. (A) Immunoblot showing that Sox2MO and Sox3MO speciﬁcally and efﬁciently block protein synthesis from co-injected utr-Sox2
and utr-Sox3mRNA, respectively. (B–E, F–I) Effects of unilateral injection (lower half) of Sox2+Sox3MO (B–E), or Sox3mRNA (F–I) on various neurogenic markers at neural plate stage.
Embryos are shown superimposed with green ﬂuorescent channel to reveal distribution of myc-GFP co-injected as lineage tracer. Asterisks indicate reductions, while arrows mark
increased or ectopic marker gene expression in the placodal or non-neural ectoderm. (J–L) Effects of unilateral injection of GR–Sox3 and DEX activation at stage 16–18 on neurogenic
markers at tail bud stages (J1–L1: injected side; J2–L2: control side). Asterisks indicate reductions in the placodal or non-neural ectoderm. (M, N) Ectopic neuronal differentiation
(arrows) after injection of GR–Eya1+GR–Six1mRNAs (M1: inj. side; M2: control side) and DEX activation at stage 16–18 is signiﬁcantly reduced after co-injection of Sox2/Sox3MO (M3:
inj. side; M4: control side; N: quantitation, Χ2 test; ⁎⁎: pb0.001). (O–R) Ectopic expression (arrows) of Sox3 (O1, O3: inj. side; O2, O4: control side) and Sox2 (P1, P3: inj. side; P2, P4:
control side) but not of NeuroD (Q1, Q3: inj. side; Q2, Q4: control side) and p27Xic1 after injection of GR–Eya1+GR–Six1 mRNAs and DEX activation at stage 16–18 persists and is more
extensive with CHX treatment (R: quantitation; Χ2 test; ⁎: pb0.05, ⁎⁎: pb0.001).
212 G. Schlosser et al. / Developmental Biology 320 (2008) 199–214regulation of placodal neurogenesis. Our data demonstrate that Eya1
and Six1 play a central role in multiple steps of placodal neurogenesis:
they regulate neuronal progenitor pool size, mediated via the SoxB1-
genes, control the onset of neuronal determination and differentia-
tion, and promote neuronal differentiation.
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